đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and immun...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00551915
Treatments Being Tested
This two-stage study evaluates the immunogenicity, safety, and tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00289913
Treatments Being Tested
To determine if there is an improvement in the immune response to HBsAg (he...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00441012
Treatments Being Tested
PR5I, a hexavalent pediatric combination vaccine is being developed to redu...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00362427
To monitor the occurrence of invasive Hib disease over time and to determin...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00855855
Treatments Being Tested
The purpose of this study is to 1) demonstrate the protective efficacy agai...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-05-21
Trial ID
NCT01545375
Treatments Being Tested